A systematic review of prevalence studies of dementia in Parkinson's disease, Mov Disord, vol.20, pp.1255-1263, 2005. ,
Association between Parkinson's disease and the HLA-DRB1 locus, Mov Disord, vol.27, pp.1104-1110, 2012. ,
Staging of neurofibrillary pathology in Alzheimer's disease: a study of the BrainNet Europe Consortium, Brain Pathol, vol.18, pp.484-496, 2008. ,
Staging/typing of Lewy body related alpha-synuclein pathology: a study of the BrainNet Europe Consortium, Acta Neuropathol, vol.117, pp.635-652, 2009. ,
Characterization of lentiviral vectormediatedgene transfer in adult mouse brain, Human Gene Therapy, vol.13, issue.7, p.19, 2002. ,
?-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation, Nature, vol.477, pp.107-110, 2011. ,
The function of ?-synuclein, Neuron, vol.79, pp.1044-1066, 2013. ,
Prion-like propagation of human brain-derived alpha-synuclein in transgenic mice expressing human wild-type alpha-synuclein, Acta Neuropathol Commun, vol.3, p.75, 2015. ,
Structural and functional characterization of two alpha-synuclein strains, Nat Commun, vol.4, p.2575, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-01183047
Mechanisms of ?-synuclein induced synaptopathy in Parkinson's disease, Front Neurosci, vol.12, p.80, 2018. ,
Seeding variability of different alpha synuclein strains in synucleinopathies, Ann Neurol, vol.85, pp.691-703, 2019. ,
Alpha-synuclein locus duplication as a cause of familial Parkinson's disease, Lancet, vol.364, pp.1167-1169, 2004. ,
Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy, Proc Natl Acad Sci, vol.97, pp.571-576, 2000. ,
HTRF: A technology tailored for drug discovery-a review of theoretical aspects and recent applications, Curr Chem Genomics, vol.3, pp.22-32, 2009. ,
Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein, Proc Natl Acad Sci, vol.106, pp.13010-13015, 2009. ,
Assessment of the efficacy of different procedures that remove and disassemble alpha-synuclein, tau and A-beta fibrils from laboratory material and surfaces, Sci Rep, vol.8, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-01871856
Detection of alpha-synuclein aggregates in gastrointestinal biopsies by protein misfolding cyclic amplification, Neurobiol Dis, vol.129, pp.38-43, 2019. ,
URL : https://hal.archives-ouvertes.fr/cea-02279266
Second consensus statement on the diagnosis of multiple system atrophy, Neurology, vol.71, pp.670-676, 2008. ,
Alpha-synuclein and neurodegenerative diseases, Nat Rev Neurosci, vol.2, pp.492-501, 2001. ,
Parkinson's disease and other alpha-synucleinopathies, Clin Chem Lab Med, vol.39, pp.308-312, 2001. ,
Propagation of alpha-synuclein strains within human reconstructed neuronal network, Stem Cell Reports, vol.12, p.7, 2018. ,
Increased immune activation by pathologic alpha-synuclein in Parkinson's disease, Ann Neurol, 2019. ,
) ?-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells, J Clin Invest, vol.121, pp.715-725, 2011. ,
Risk and incidence of dementia in a cohort of older subjects with Parkinson's disease in the United Kingdom, Mov Disord, vol.19, pp.1043-1049, 2004. ,
Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease, Nat Med, vol.14, pp.504-506, 2008. ,
) alpha-Synuclein strains target distinct brain regions and cell types, Nat Neurosci, 2019. ,
Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation, Nat Med, vol.14, pp.501-503, 2008. ,
Pathological ?-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice, Science, vol.338, pp.949-953, 2012. ,
Exogenous alpha-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells, Proc Natl Acad Sci, vol.106, 2009. ,
Prion-like spreading of pathological alpha-synuclein in brain, Brain, vol.136, pp.1128-1138, 2013. ,
Prion-like spreading of pathological ?-synuclein in brain, Brain, vol.136, pp.1128-1138, 2013. ,
, Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop, vol.47, pp.1113-1124, 1996.
A novel link between the conformations, exposure of specific epitopes, and subcellular localization of ?-synuclein, Biochim Biophys Acta, vol.1850, pp.2497-2505, 2015. ,
Seeded aggregation and toxicity of ?-synuclein and tau: cellular models of neurodegenerative diseases, J Biol Chem, vol.285, pp.34885-34898, 2010. ,
Detection of elevated levels of soluble alpha-synuclein oligomers in post-mortem brain extracts from patients with dementia with Lewy bodies, Brain, vol.132, pp.1093-1101, 2009. ,
) ?-Synuclein strains cause distinct synucleinopathies after local and systemic administration, Nature, vol.522, pp.340-344, 2015. ,
Cellular milieu imparts distinct pathological ?-synuclein strains in ?-synucleinopathies, Nature, vol.557, pp.558-563, 2018. ,
FK506 reduces neuroinflammation and dopaminergic neurodegeneration in an ?-synuclein-based rat model for Parkinson's disease, Neurobiol Aging, vol.36, pp.1559-1568, 2015. ,
Efficient and stable transduction of dopaminergic neurons in rat substantia nigra by rAAV 2/1, 2/2, 2/5, 2/6.2, 2/7, 2/8 and 2/9, Gene Ther, vol.18, pp.517-527, 2011. ,
Longitudinal follow-up and characterization of a robust rat model for Parkinson's disease based on overexpression of alpha-synuclein with adeno-associated viral vectors, Neurobiol Aging, vol.36, pp.1543-1558, 2015. ,
Fibrillar alphasynuclein and huntingtin exon 1 assemblies are toxic to the cells, Biophys J, vol.102, pp.2894-2905, 2012. ,
Mutation in the alpha-synuclein gene identified in families with Parkinson's disease, Science, vol.276, pp.2045-2047, 1997. ,
MDS clinical diagnostic criteria for Parkinson's disease, Mov Disord, vol.30, pp.1591-1601, 2015. ,
Evidence for alpha-synuclein prions causing multiple system atrophy in humans with parkinsonism, Proc Natl Acad Sci, vol.112, pp.5308-5317, 2015. ,
Lewy body extracts from Parkinson disease brains trigger ?-synuclein pathology and neurodegeneration in mice and monkeys, Ann Neurol, vol.75, pp.351-362, 2014. ,
URL : https://hal.archives-ouvertes.fr/inserm-02439340
Designed-based stereology in neuroscience, Neuroscience, vol.130, issue.4, pp.813-844, 2005. ,
Discriminating ?-synuclein strains in Parkinson's disease and multiple system atrophy, 2020. ,
Differential membrane binding and seeding of distinct alpha-synuclein fibrillar polymorphs, Biophys J, vol.118, pp.1301-1320, 2020. ,
URL : https://hal.archives-ouvertes.fr/cea-02480815
) alpha-synuclein assemblies sequester neuronal alpha3-Na+/K+-ATPase and impair Na+ gradient, EMBO J, vol.34, pp.2408-2423, 2015. ,
Unique alpha-synuclein pathology within the amygdala in Lewy body dementia: implications for disease initiation and progression, Acta Neuropathol Commun, vol.7, p.142, 2019. ,
Alpha-synuclein in Lewy bodies, Nature, vol.388, pp.839-840, 1997. ,
Structural heterogeneity of alpha-synuclein fibrils amplified from patient brain extracts, Nat Commun, vol.10, p.5535, 2019. ,
Dynamic modeling of ?-synuclein aggregation in dopaminergic neuronal system indicates points of neuroprotective intervention: experimental validation with implications for Parkinson's therapy, Neuroscience, vol.199, pp.303-317, 2011. ,
T cells from patients with Parkinson's disease recognize alpha-synuclein peptides, Nature, vol.546, pp.656-661, 2017. ,
Functional cooperation of alpha-synuclein and VAMP2 in synaptic vesicle recycling, Proc Natl Acad Sci, vol.116, pp.11113-11115, 2019. ,
Modeling Parkinson's disease pathology by combination of fibril seeds and alpha-synuclein overexpression in the rat brain, Proc Natl Acad Sci, vol.114, pp.8284-8293, 2017. ,
Structural disorder of monomeric ?-synuclein persists in mammalian cells, Nature, vol.530, pp.45-50, 2016. ,
Exogenous ?-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death, Neuron, vol.72, pp.57-71, 2011. ,
Accumulation of alpha-synuclein/ NACP is a cytopathological feature common to Lewy body disease and multiple system atrophy, Acta Neuropathol, vol.96, pp.445-452, 1998. ,
Alpha-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy, Neurosci Lett, vol.249, pp.180-182, 1998. ,
alpha-synuclein multimers cluster synaptic vesicles and attenuate recycling, Curr Biol, vol.24, pp.2319-2326, 2014. ,
?-synuclein multimers cluster synaptic vesicles and attenuate recycling, Curr Biol, vol.24, pp.2319-2326, 2014. ,
Transmission of multiple system atrophy prions to transgenic mice, Proc Natl Acad Sci, vol.110, pp.19555-19560, 2013. ,
In vivo demonstration that alpha-synuclein oligomers are toxic, Proc Natl Acad Sci, vol.108, pp.4194-4199, 2011. ,
The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia, Ann Neurol, vol.55, pp.164-173, 2004. ,
, Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations